financetom
Business
financetom
/
Business
/
Can Whirlpool's new fully automatic washing machine wash away two years of underperformance?
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Can Whirlpool's new fully automatic washing machine wash away two years of underperformance?
Sep 23, 2022 7:28 AM

Share Market Live

NSE

Whirlpool of India Ltd has forayed into the Fully Automatic Front Load Washing Machine space, an area they have considered to be a "white space" all along. Until date, the company only sold semi-automatic washing machines.

The product will be manufactured at the company's Puducherry plant, for which it has made an investment of Rs 115 crore.

In an interview with CNBC TV-18, Managing Director Vishal Bhola said that consumers are demanding higher capacity products and are willing to splurge for the same. "There is a lot of demand coming back in the mid and premium segment where consumers are not only coming back to the market, they are actually demanding more premium products which have higher capacities," he said.

However, demand trends in the entry level segment are not as robust as seen within the premium segment. The company, in its annual report, attributed this to consumers getting impacted due to a rise in the cost of living and therefore choosing to defer discretionary purchases.

"In the entry segment the consumers are still being a bit more picky about what they want and a bit more conscious in terms of the value they are seeking out of what they buy," Bhola said.

Having hiked prices by 6-10 percent over the last 12 months, Whirlpool's India business intends to grow in double-digits over the next few years, which according to Bhola, is also the projected industry growth rate, but he is hopeful that the company will grow faster than the industry.

Whirlpool of India has spent over Rs 900 crore over the last 2-3 years for various initiatives, including the expansion of its capacity at its Puducherry unit, expanding its refrigeration plant in Pune and more. These Rs 900 crore also include the Rs 600 crore which the company spent in financial year 2022 to increase its stake in Elica PB India, in which it now owns 87.25 percent stake. Elica PB India has its manufacturing facility situated at Pune and distributes kitchen appliances across the country.

However, Bhola does not see the need for any fresh capex. "As of now, where we are, we feel very comfortable about the spends which we have made, and they should take us into the next couple of years," he said. However, he added that the company would not mind utilising the cash in its books in case suitable opportunity arises. As of March 31, the total consolidated cash balance on the company's books stood at Rs 1,610 crore.

However, shares of Whirlpool are down 40 percent over the last two years. The company has also lost market share worth nearly 160 basis points year-to-date, compared to FY22, according to a note from Emkay.

"With the emergence of new labels and private players, market share of the top five brands across categories has been constantly shrinking," the note from Emkay, dated September 8 this year, said.

Shares of Whirlpool of India ended Friday's trading session down 1.65 percent at Rs 1,658.45.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Johnson & Johnson Secures FDA Approval for Tremfya as Ulcerative Colitis Treatment
Johnson & Johnson Secures FDA Approval for Tremfya as Ulcerative Colitis Treatment
Sep 12, 2024
05:07 AM EDT, 09/12/2024 (MT Newswires) -- Johnson & Johnson ( JNJ ) said Wednesday that the US Food and Drug Administration has approved Tremfya for the treatment of adults with moderately to severely active ulcerative colitis. The company said the approval is supported by data from the ongoing phase 2b/3 study evaluating Tremfya in adult patients with moderately to...
Nippon Steel, U.S. Steel make last-ditch effort to win US nod, source says
Nippon Steel, U.S. Steel make last-ditch effort to win US nod, source says
Sep 12, 2024
WASHINGTON (Reuters) -A top Nippon Steel executive and U.S. Steel's CEO are meeting with senior U.S. officials on Wednesday in an effort to salvage Nippon's $14.9 billion bid for U.S. Steel, a person familiar with the matter said. The meeting, including Takahiro Mori, a key Nippon negotiator on the deal, and U.S. Steel CEO David Burritt, is also expected to...
Aviat Networks Delays 10-K Filing Amid Internal Control Assessment
Aviat Networks Delays 10-K Filing Amid Internal Control Assessment
Sep 12, 2024
05:10 AM EDT, 09/12/2024 (MT Newswires) -- Aviat Networks ( AVNW ) said late Wednesday it has filed a notification of late filing for its annual report on Form 10-K for the fiscal year ended June 28. The company said the delay was due to the need for additional time to finalize its internal control assessments and complete closing procedures....
Ascendis Pharma Gets FDA Orphan Drug Designation for Hypoparathyroidism Treatment
Ascendis Pharma Gets FDA Orphan Drug Designation for Hypoparathyroidism Treatment
Sep 12, 2024
05:02 AM EDT, 09/12/2024 (MT Newswires) -- Ascendis Pharma ( ASND ) said late Wednesday the US Food & Drug Administration has granted orphan drug designation to Yorvipath, providing seven years of market exclusivity in the US for the treatment of hypoparathyroidism in adults. Orphan drug designation provides drug developers with certain benefits and incentives, including the waiver of FDA...
Copyright 2023-2026 - www.financetom.com All Rights Reserved